ES8605147A1 - Procedimiento de preparar compuestos para estimular el cre- cimiento y-o la produccion de leche de animales domesticos - Google Patents

Procedimiento de preparar compuestos para estimular el cre- cimiento y-o la produccion de leche de animales domesticos

Info

Publication number
ES8605147A1
ES8605147A1 ES541532A ES541532A ES8605147A1 ES 8605147 A1 ES8605147 A1 ES 8605147A1 ES 541532 A ES541532 A ES 541532A ES 541532 A ES541532 A ES 541532A ES 8605147 A1 ES8605147 A1 ES 8605147A1
Authority
ES
Spain
Prior art keywords
compound
animals
synthesis
preparation
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES541532A
Other languages
English (en)
Other versions
ES541532A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TECHLAND SA
Original Assignee
TECHLAND SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19730232&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8605147(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by TECHLAND SA filed Critical TECHLAND SA
Publication of ES541532A0 publication Critical patent/ES541532A0/es
Publication of ES8605147A1 publication Critical patent/ES8605147A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18Acyclic radicals, substituted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/655Somatostatins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/5555Muramyl dipeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6062Muramyl peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Feed For Specific Animals (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

PROCEDIMIENTO DESTINADO A AUMENTAR EL CRECIMIENTO Y EL DESARROLLO DE LOS ANIMALES DOMESTICOS DE VARIAS ESPECIES, Y ESPECIALMENTE LA BOVINA, PARA LA PRODUCCION DE CARNE. DICHO PROCESO EMPIEZA POR INMUNIZAR DIRECTAMENTE POR MEDIO DEL PEPTIDO DE FOMENTO DE CRECIMIENTO (GPP) AL ANIMAL RECEPTOR CUYO DESARROLLO Y CRECIMIENTO SE PRETENDE AUMENTAR. EL INGREDIENTE ACTIVO DE LA NUEVA VACUNA ES UN COMPUESTO QUE RESULTA DEL ACOPLAMIENTO DE LA N-ACETILMURAMIL-L-ALANIL-D-ISOFLUTAMINA CON SOMATOSTATINA EN ESTADO NATURAL U OXIDADO O EN LA PROFORMA O SUS PREPROFORMAS, CON LO QUE SE PRETENDE INHIBIR LA SOMATOSTATINA ENDOGENA DEL ANIMAL QUE EL NEUROPEPTIDO QUE INHIBE LA LIBERACION DE LA HORMONA AL CRECIMIENTO.
ES541532A 1984-03-26 1985-03-25 Procedimiento de preparar compuestos para estimular el cre- cimiento y-o la produccion de leche de animales domesticos Expired ES8605147A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU85269A LU85269A1 (fr) 1984-03-26 1984-03-26 Composes nouveaux de somatostatine,procede pour leur synthese,preparation a usage veterinaire contenant lesdits composes et procede pour le traitement d'animaux

Publications (2)

Publication Number Publication Date
ES541532A0 ES541532A0 (es) 1986-04-01
ES8605147A1 true ES8605147A1 (es) 1986-04-01

Family

ID=19730232

Family Applications (1)

Application Number Title Priority Date Filing Date
ES541532A Expired ES8605147A1 (es) 1984-03-26 1985-03-25 Procedimiento de preparar compuestos para estimular el cre- cimiento y-o la produccion de leche de animales domesticos

Country Status (14)

Country Link
EP (1) EP0157753B1 (es)
JP (1) JPS60222499A (es)
KR (1) KR850006942A (es)
AT (1) ATE30729T1 (es)
AU (1) AU4037485A (es)
DE (1) DE3560949D1 (es)
DK (1) DK133085A (es)
ES (1) ES8605147A1 (es)
GR (1) GR850746B (es)
IL (1) IL74701A0 (es)
LU (1) LU85269A1 (es)
NO (1) NO851084L (es)
PT (1) PT80159B (es)
ZA (1) ZA852224B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599229A (en) * 1985-09-09 1986-07-08 International Minerals & Chemical Corp. Method of promoting animal growth using antibodies against somatostatin
HU906340D0 (en) * 1986-10-13 1991-04-29 Sandoz Ag Synthesis in solid phase for producing peptonic alcohols
CH679045A5 (es) * 1987-06-29 1991-12-13 Sandoz Ag
FR2622455B1 (fr) * 1987-11-04 1991-07-12 Agronomique Inst Nat Rech Application du facteur de stimulation de la secretion de l'hormone de croissance humaine, de ses fragments actifs et des analogues correspondants, pour augmenter la production laitiere et le poids des nouveau-nes chez les mammiferes
US5552534A (en) * 1991-08-22 1996-09-03 The Trustees Of The University Of Pennsylvania Non-Peptide peptidomimetics
WO1993013791A1 (en) * 1992-01-20 1993-07-22 Peptech (Uk) Limited Use of muramyl peptides for enhancing animal production
IT1283134B1 (it) * 1996-07-08 1998-04-07 Dox Al Italia Spa Derivati sintetici e semisintetici di somatostatine utili nella stimolazione della crescita corporea, in particolare in
WO2001036643A1 (en) 1999-11-19 2001-05-25 Transkaryotic Therapies, Inc. Nucleic acid construct for optimized production of products
FR2852247A1 (fr) * 2003-03-11 2004-09-17 Centre Nat Rech Scient Utilisation de ligands peptidiques de recepteurs de la membrane plasmique et de leurs analogues pour moduler l'activite des mitochondries
WO2013032011A1 (ja) * 2011-09-04 2013-03-07 株式会社糖鎖工学研究所 糖鎖付加ポリペプチドおよび当該ポリペプチドを含む医薬組成物
AU2012302637B2 (en) * 2011-09-04 2016-09-15 Glytech, Inc. Glycosylated polypeptide and drug composition containing said polypeptide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2522967B1 (fr) * 1982-03-15 1986-03-07 Anvar Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant

Also Published As

Publication number Publication date
KR850006942A (ko) 1985-10-25
LU85269A1 (fr) 1985-10-14
ATE30729T1 (de) 1987-11-15
DK133085A (da) 1985-09-27
EP0157753A1 (en) 1985-10-09
GR850746B (es) 1986-05-13
DE3560949D1 (en) 1987-12-17
ES541532A0 (es) 1986-04-01
JPS60222499A (ja) 1985-11-07
ZA852224B (en) 1985-11-27
IL74701A0 (en) 1985-06-30
NO851084L (no) 1985-09-27
DK133085D0 (da) 1985-03-25
PT80159A (en) 1985-04-01
AU4037485A (en) 1985-10-03
EP0157753B1 (en) 1987-11-11
PT80159B (en) 1986-11-10

Similar Documents

Publication Publication Date Title
ZM4185A1 (en) Novel compounds
ES8605147A1 (es) Procedimiento de preparar compuestos para estimular el cre- cimiento y-o la produccion de leche de animales domesticos
FR2601855B1 (fr) Composition destinee a la conservation du fourrage.
JPS6426567A (en) Pyrazine compound, manufacture and plant growth regulant composition
ZA828085B (en) Derivatives of cis,endo-2-azabicyclo-(3.3.0)-octane-3-carboxylic acid,a process for their preparation,agents containing these compounds and their use
EP0276007A3 (en) Fur animal feed and a method for preparing the same
JPS57150349A (en) New feedstuff additives
IT8522994A0 (it) Procedimento per preparare l'acido 3-idrossi-3-metilglutarico.
JPS57181057A (en) Manufacture of 4-amino-3,5,6-trichloropicolinic acid
ES8505915A1 (es) Metodo de preparar dimetiloctenonas
IL74660A0 (en) Inner salts of phosphonic acids,their production and their use as plant fungicides
IL69646A0 (en) Phenoxyalkanoic acid derivatives,their preparation and use for regulating plant growth
NZ233168A (en) Preparation of 5,8,11,14-eicosatetraynoic acid
IT1213328B (it) Derivati dell'acido 2,2-dimetil-ciclopropancarbossilico .
MN173A6 (en) Triethanolamine salt of 2,4-chlorophenoxycetic acid as biological stimulant
OA08141A (en) The manufacture of high protein cow blood powder by a thermal process.
UA11677A1 (uk) Регулятор росту рослиh люцерhи
ES536877A0 (es) Procedimiento de preparacion de 1,1-dioxido del acido 6,6-dibromopenicilanico.
IT8519281A0 (it) 2,6-xilidide dell'acido l-n-n-propilpipecolico eprocedimento per la sua preparazione.
IT8522805A0 (it) Procedimento per preparare l'acido 2,2-dimetil-5-(2,5-xililossi)valeri co.